Thillai V Sekar Selected Research

poly(lactic-glycolic acid)-poly(ethyleneglycol) copolymer

6/2015	Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
3/2015	Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thillai V Sekar Research Topics

Disease

13	Neoplasms (Cancer) 04/2018 - 04/2011
5	Triple Negative Breast Neoplasms 01/2018 - 01/2014
3	Breast Neoplasms (Breast Cancer) 06/2015 - 04/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2016
1	Carcinogenesis 10/2016
1	Herpes Simplex 01/2016
1	Carcinoma (Carcinomatosis) 06/2015
1	Male Breast Neoplasms (Male Breast Cancer) 06/2015
1	Neoplasm Metastasis (Metastasis) 03/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2018 - 12/2013
3	tretazicarIBA 01/2018 - 01/2014
3	ProdrugsIBA 01/2018 - 01/2014
3	MicroRNAs (MicroRNA)IBA 12/2016 - 12/2013
3	PolymersIBA 12/2016 - 03/2015
3	EnzymesIBA 01/2016 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 01/2014
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2018 - 01/2016
2	Thymidine KinaseIBA 01/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 12/2016 - 02/2016
2	Estrogens (Estrogen)FDA Link 10/2016 - 06/2015
2	Hormones (Hormone)IBA 06/2015 - 04/2011
2	poly(lactic-glycolic acid)-poly(ethyleneglycol) copolymerIBA 06/2015 - 03/2015
2	Estrogen ReceptorsIBA 06/2015 - 04/2011
1	ChromatinIBA 04/2018
1	NitroreductasesIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 12/2016
1	Gemcitabine FDA Link 12/2016
1	Tumor Suppressor Protein p53IBA 12/2016
1	LigandsIBA 10/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2016
1	Orlistat (Xenical)FDA Link 02/2016
1	Drug CombinationsIBA 06/2015
1	EmulsionsIBA 06/2015
1	afimoxifene (hydroxytamoxifen)IBA 06/2015
1	NucleotidesIBA 06/2015
1	Tamoxifen FDA LinkGeneric 06/2015
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 06/2015
1	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015
1	Small Untranslated RNAIBA 06/2015
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 06/2015
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2015
1	Peptides (Polypeptides)IBA 03/2015
1	Histones (Histone)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	AntioxidantsIBA 01/2015
1	9-(4-fluoro-3-hydroxymethylbutyl)guanineIBA 01/2014
1	Phosphotransferases (Kinase)IBA 12/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2011
1	Growth Factor ReceptorsIBA 04/2011

Therapy/Procedure

9	Therapeutics 01/2018 - 12/2013
3	Drug Therapy (Chemotherapy) 12/2016 - 01/2014
1	Microbubbles 01/2018
1	Complementary Therapies (Alternative Medicine) 01/2014
1	Precision Medicine 01/2014
1	Radiotherapy 01/2014